Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Lactobacillus plantarum {L. plantarum} - Blautia |
👶
The Protection of Lactiplantibacillus plantarum CCFM8661 Against Benzopyrene-Induced Toxicity via Regulation of the Gut Microbiota. Frontiers in immunology (Front Immunol ) Vol: 12 Issue Pages: 736129 Pub: 2021 Epub: 2021 Aug 10 Authors Yu L , Zhang L , Duan H , Zhao R , Xiao Y , Guo M , Zhao J , Zhang H , Chen W , Tian F , Html Article Publication |
| Lactobacillus plantarum {L. plantarum} - Blautia |
📓
Effect of Lactiplantibacillus plantarum LPJZ-658 on caecum microbiota and serum metabolomics of Luhua broiler. Frontiers in microbiology (Front Microbiol ) Vol: 16 Issue Pages: 1622009 Pub: 2025 Epub: 2025 Aug 20 Authors Li M , Liu Z , Chen C , Liu Z , Liu L , Html Article Publication |
| Lactobacillus plantarum {L. plantarum} - Blautia |
👶
Lactobacillus plantarum attenuates glucocorticoid-induced osteoporosis by altering the composition of rat gut microbiota and serum metabolic profile. Frontiers in immunology (Front Immunol ) Vol: 14 Issue Pages: 1285442 Pub: 2023 Epub: 2024 Jan 9 Authors Li S , Han X , Liu N , Chang J , Liu G , Hu S , Html Article Publication |
| Lactobacillus plantarum {L. plantarum} - Blautia |
📓
The impact of oral consumption of Lactobacillus plantarum P-8 on faecal bacteria revealed by pyrosequencing. Beneficial microbes (Benef Microbes ) Vol: 6 Issue 4 Pages: 405-13 Pub: 2015 Epub: 2015 Feb 12 Authors Kwok LY , Guo Z , Zhang J , Wang L , Qiao J , Hou Q , Zheng Y , Zhang H , Publication Publication |
| Lactobacillus plantarum {L. plantarum} - Blautia |
📓
Exopolysaccharides from Lactobacillus plantarum YW11 improve immune response and ameliorate inflammatory bowel disease symptoms. Acta biochimica Polonica (Acta Biochim Pol ) Vol: 67 Issue 4 Pages: 485-493 Pub: 2020 Dec 17 Epub: Authors Min Z , Xiaona H , Aziz T , Jian Z , Zhennai Y , Publication |
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
